Short-Term Dietary Oatmeal Interventions in Adults With Type 2 Diabetes: A Forgotten Tool
Publication date: Available online 25 September 2019Source: Canadian Journal of DiabetesAuthor(s): Maximilian Andreas Storz, Federica IraciAbstractDietary modifications play a central role in the treatment of diabetes. Educating and empowering individuals to make better dietary choices is a challenging task. In this context, 1 potential dietetic approach to achieve better glycemic control in type 2 diabetes is often overlooked: the use of short-term dietary oatmeal interventions. This concept was described more than 100 years ago by the German diabetologist Carl von Noorden. It is still applied in several German hospitals, but in a modified form. Although von Noorden initially prescribed a diet including oatmeal, butter and vegetables, some physicians nowadays tend to omit butter from the diet. The result is a hypocaloric, plant-based dietary intervention that is low in fat and excludes animal protein for a short period. This short-term dietary intervention has been associated with a significant reduction in mean blood glucose concentrations and an improved insulin sensitivity in patients with type 2 diabetes. Almost forgotten, short-term dietary oatmeal interventions are an economical, yet highly effective tool to achieve better glycemic control in patients with type 2 diabetes.RésuméLes modifications alimentaires jouent un rôle central dans le traitement du diabète. Il est difficile d’éduquer et de responsabiliser les individus &agrav...
CONCLUSIONS These results indicate that GDLP against T2DM-induced hepatic steatosis, oxidative stress, and inflammation by improving the Nrf2/HO-1 signaling pathway in db/db mice, suggesting the GDLP may serve as an effective strategy for in fatty liver treatment. PMID: 32245940 [PubMed - as supplied by publisher]
Publication date: Available online 4 April 2020Source: Journal of Ayurveda and Integrative MedicineAuthor(s): Naresh Kumar P, Ragavendrasamy Balakrishnan, Vibhas Kana
TYPE 2 diabetes requires one to lead a healthy lifestyle to keep blood sugar levels under control. Since exercise plays a key role in controlling blood sugar levels, the current lockdown poses a threat to type 2 diabetes management. Luckily, there is a simple activity you can do from the comfort of your home that has proven to lower post-meal blood sugar levels.
Publication date: Available online 5 April 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Omid Asbaghi, Faezeh Fouladvand, Sajjad Moradi, Damoon Ashtary-Larky, Razieh Choghakhori, Amir Abbasnezhad
Authors: Popa A, Georgescu M, Popa SG, Nica AE, Georgescu EF Abstract Steadily, cancer is becoming the first cause of mortality, with over 9 million deaths estimated in 2018. Increasing evidence supports a direct association between obesity, type 2 diabetes mellitus (T2DM) and cancer, with a higher risk of cancer mortality especially for some of the most common malignancies, such as breast, colon, and rectal cancers. So far, several mechanisms underlying the cancer-diabetes relationship have been investigated revealing dysregulations of the insulin-insulin-like growth factor (IGF) system as the most important parad...
TYPE 2 diabetes is a chronic condition that can prove life-threatening so it is vital to spot the warning signs as soon as they appear. One particular symptom is also associated with COVID-19 - have you spotted this?
Conclusions: In the current study, the prevalence of depression among diabetic outpatients was higher than that of studies conducted in other settings. Depression was significantly associated with female sex, rural residency, type 2 diabetes mellitus, duration of illness> 6 years, high fear of complications, and poor social support. PMID: 32243106 [PubMed - as supplied by publisher]
This study was an open-label, parallel controlled study. Patients were included if they were newly diagnosed with type 2 diabetes (
CONCLUSIONS In this study, we screened 104 lncRNA therapeutic targets and several signaling pathways (Wnt, PPAR, amino acid metabolism signaling pathway, mTOR, and lipid metabolism-related pathways) of liraglutide against T2DM based on lncRNA sequencing. PMID: 32238798 [PubMed - in process]